Health Canada — Medical Devices · Canada · 2017-04-04 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Siemens Healthcare Diagnostics has confirmed that the Advia Centaur BR (ca 27.29) assay does not dilute linearly when used with multi-diluent 1 kit lots ending in 2577 and all future lots until further notice. When diluted, some samples over-recover the expected neat value by greater than 120%.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.